January 2, 2019
Dermavant Sciences Announces Appointment of Dr. Philip M. Brown as Chief Medical Officer
Dr. Brown previously served as Head of Global Pharmaceutical Development at Galderma and has over 25 years of experience leading clinical dev...
Read Press ReleaseDermavant’s
Growing Pipeline
Dermavant is developing investigational drugs to treat atopic dermatitis, acne, hyperhidrosis and other inflammatory skin diseases and medical dermatologic conditions.
Patient-Focused
Innovation
The patient is at the heart of everything we do. It is for them that we harness scientific innovations to provide new treatment options for inflammatory skin diseases and medical dermatologic conditions with unmet medical needs.
January 2, 2019
Dermavant Sciences Announces Appointment of Dr. Philip M. Brown as Chief Medical Officer
Patient-Focused
Innovation
The patient is at the heart of everything we do. It is for them that we harness scientific innovations to provide new treatment options for inflammatory skin diseases and medical dermatologic conditions with unmet medical needs.
